newsfilter
← Latest News
ACCESS Newswire·

NLS Pharmaceutics Announces Publication of New Patent Application for Next-Gen Dual Non-Sulfonamide Orexin Receptor Agonists (DOXA)

ZURICH, SWITZERLAND / ACCESSWIRE / June 11, 2024 / NLS Pharmaceutics Ltd. , a Swiss clinical-stage biopharmaceutical company dedicated to pioneering